ANL 28.52 No Change ▼ 0.00 (0%)
ASC 16.68 Decreased By ▼ -0.03 (-0.18%)
ASL 23.76 Increased By ▲ 0.01 (0.04%)
AVN 94.24 Increased By ▲ 0.34 (0.36%)
BOP 9.47 No Change ▼ 0.00 (0%)
BYCO 9.56 Decreased By ▼ -0.02 (-0.21%)
DGKC 110.50 No Change ▼ 0.00 (0%)
EPCL 47.45 No Change ▼ 0.00 (0%)
FCCL 21.28 Increased By ▲ 0.13 (0.61%)
FFBL 27.97 No Change ▼ 0.00 (0%)
FFL 19.28 Increased By ▲ 0.01 (0.05%)
HASCOL 14.31 No Change ▼ 0.00 (0%)
HUBC 86.00 No Change ▼ 0.00 (0%)
HUMNL 7.30 Increased By ▲ 0.04 (0.55%)
JSCL 31.47 No Change ▼ 0.00 (0%)
KAPCO 40.73 No Change ▼ 0.00 (0%)
KEL 4.11 Increased By ▲ 0.01 (0.24%)
LOTCHEM 16.20 Increased By ▲ 0.01 (0.06%)
MLCF 43.02 No Change ▼ 0.00 (0%)
PAEL 39.86 Increased By ▲ 0.01 (0.03%)
PIBTL 12.91 Increased By ▲ 0.01 (0.08%)
POWER 11.40 No Change ▼ 0.00 (0%)
PPL 93.29 No Change ▼ 0.00 (0%)
PRL 23.80 No Change ▼ 0.00 (0%)
PTC 9.30 No Change ▼ 0.00 (0%)
SILK 1.20 No Change ▼ 0.00 (0%)
SNGP 44.33 Decreased By ▼ -0.02 (-0.05%)
TRG 108.48 No Change ▼ 0.00 (0%)
UNITY 33.15 No Change ▼ 0.00 (0%)
WTL 1.12 No Change ▼ 0.00 (0%)
BR100 4,856 Decreased By ▼ -9.94 (-0.2%)
BR30 24,724 Decreased By ▼ -96.85 (-0.39%)
KSE100 45,868 Decreased By ▼ -116.42 (-0.25%)
KSE30 19,061 Decreased By ▼ -87.18 (-0.46%)
World

Brazil's Bolsonaro says he was right to question Chinese COVID-19 vaccine

  • This 50% is good, is it? All the (criticism) I got for my comments, and now they are seeing the truth. Four months of being lambasted because of the vaccine.
  • Brazil's government closed a deal with the Butantan Institute to buy up to 100 million doses of the Chinese vaccine.
13 Jan 2021

SAO PAULO: Brazilian President Jair Bolsonaro said on Wednesday he was right to criticize the credibility of a Chinese COVID-19 vaccine developed by Sinovac Biotech that posted disappointing efficacy results in local trials.

On Tuesday, researchers in Sao Paulo state announced that the Chinese vaccine was 50.4% effective at preventing symptomatic infections in a local trial - barely enough for regulatory approval and well below the rate announced last week.

Bolsonaro, a far-right former army captain, is a longstanding China hawk. He has repeatedly criticized the Sinovac shot, which was being late-stage tested by Sao Paulo's Butantan Institute, as untrustworthy. He previously said his government would not buy the Chinese vaccine but later relented as criticism of Brazil's vaccine rollout has grown.

Speaking to supporters outside his residence, Bolsonaro made light of Sinovac's trial results so far, saying he had been unfairly maligned for questioning the shot.

"This 50% is good, is it? All the (criticism) I got for my comments, and now they are seeing the truth. Four months of being lambasted because of the vaccine," he said.

Nonetheless, Bolsonaro said he had no role in greenlighting the Sinovac shot as it was up to federal health regulator Anvisa to decide on whether to approve it for use.

Last week, Brazil's government closed a deal with the Butantan Institute to buy up to 100 million doses of the Chinese vaccine. The government will receive an initial 46 million doses with another 54-million dose option later.